OTCMKTS:CMPD CompuMed (CMPD) Stock Price, News & Analysis $3.06 +0.03 (+0.99%) (As of 10/29/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsShort Interest About CompuMed Stock (OTCMKTS:CMPD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CompuMed alerts:Sign Up Key Stats Today's Range$3.06▼$3.0650-Day Range$3.03▼$3.7352-Week Range$1.48▼$3.99Volume120 shsAverage Volume2,090 shsMarket Capitalization$4.05 millionP/E Ratio27.82Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.Read More… Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Receive CMPD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CompuMed and its competitors with MarketBeat's FREE daily newsletter. Email Address CMPD Stock News HeadlinesCMPD to discuss theft ring caseAugust 24, 2024 | yahoo.comCompumed Inc.May 23, 2024 | wsj.comThe real reason Elon is fully endorsing TrumpElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. October 30, 2024 | Porter & Company (Ad)CompuMed, Inc.: CompuMed, FireStarter Collaborate to Further Shared Vision of Saving More Lives through Organ Donation and TransplantationMay 1, 2024 | finanznachrichten.deCompuMed, Inc. (CMPD) Stock Price, News, Quote & History - Yahoo FinanceApril 24, 2024 | finance.yahoo.comCMPD: Man arrested in California for killings of mom, 2 kids in CharlotteMarch 20, 2024 | yahoo.comCompuMed, Inc.: CompuMed Expands Cardiology Services to Rural and Regional Hospitals, Revolutionizing Patient CareMarch 12, 2024 | finanznachrichten.deCompuMed CEO Lee Keddie Joins The Alliance National Innovation Leadership CouncilMarch 22, 2023 | finance.yahoo.comSee More Headlines CMPD Stock Analysis - Frequently Asked Questions How have CMPD shares performed this year? CompuMed's stock was trading at $2.05 at the start of the year. Since then, CMPD shares have increased by 49.3% and is now trading at $3.06. View the best growth stocks for 2024 here. How were CompuMed's earnings last quarter? CompuMed, Inc. (OTCMKTS:CMPD) issued its quarterly earnings data on Wednesday, August, 14th. The company reported $0.08 earnings per share for the quarter. The business had revenue of $1.64 million for the quarter. CompuMed had a net margin of 2.37% and a trailing twelve-month return on equity of 4.54%. When did CompuMed's stock split? CompuMed's stock reverse split on the morning of Saturday, May 21st 2022. The 1-25 reverse split was announced on Saturday, May 21st 2022. The number of shares owned by shareholders was adjusted after the market closes on Saturday, May 21st 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of CompuMed? Shares of CMPD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of CompuMed own? Based on aggregate information from My MarketBeat watchlists, some other companies that CompuMed investors own include Yamana Gold (AUY) and Agnico Eagle Mines (AEM). Company Calendar Last Earnings8/14/2024Today10/30/2024Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Health Information Services Sub-IndustryBusiness Services Current SymbolOTCMKTS:CMPD CUSIPN/A CIKN/A Webwww.compumed.net Phone(310) 258-5000Fax310-645-5880Employees8Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.11 Trailing P/E Ratio27.82 Forward P/E RatioN/A P/E GrowthN/ANet Income$-30,000.00 Net Margins2.37% Pretax Margin2.29% Return on Equity4.54% Return on Assets3.27% Debt Debt-to-Equity Ratio0.05 Current Ratio2.49 Quick Ratio2.15 Sales & Book Value Annual Sales$5.84 million Price / Sales0.69 Cash Flow$0.43 per share Price / Cash Flow7.10 Book Value$2.42 per share Price / Book1.26Miscellaneous Outstanding Shares1,322,000Free Float1,031,000Market Cap$4.05 million OptionableNot Optionable Beta0.24 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:CMPD) was last updated on 10/30/2024 by MarketBeat.com Staff From Our PartnersThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | SponsoredThis biotech's ONE drug could change medicine as we know itThis Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses...Smallcaps Daily | Sponsored2 Pro Traders… 4 Livestreams… 4 Live TradesThe Zero Day Loophole: The Secret of HUGE Overnight Profits from Government ReportsMonument Traders Alliance | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredIs your portfolio prepared for AI 2.0?AI has exploded ever since ChatGPT set the world on fire near the end of 2022. Numerous companies with conn...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CompuMed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CompuMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.